LIPOSOME COMPOSITION FOR REDUCTION OF LIPOSOME INDUCED COMPLEMENT ACTIVATION
01645/KOLNP/2005 A (1645/KOLNP/2005)
Filed on 2005-08-17
Publication date 2007-02-09
A method for reducing complement activation upon in vivo administration of a liposome preparation containing an entrapped therapeutic agent is described. The method involves providing liposomes having a polyethylene-glycol-derived neutral lipopolymer. (FIG). nil
Applicant
ALZA CORPORATION. AND YISSUM RESEARCH DEVELOPMENT COMPANY., Address of the Applicant: 1900 CHARLESTON ROAD, M 10-3, P.O.BOX 7210, MOUNTAIN VIEW, CA 94039-7210, USA. AND THE HEBREW UNIVERSITY OF JERUSALEM, ISRAEL, HI-TECH PARK, EDMOND J. SAFRA CAMPUS, P.O.BOX 39135, GIAT RAM, 91390 JERUSALEM , ISRAEL.
International Information
Classification
A61K
Publication number
WO 04/078121